- freely available
Immunomodulatory Effects of Domoic Acid Differ Between In vivo and In vitro Exposure in Mice
AbstractThe immunotoxic potential of domoic acid (DA), a well-characterized neurotoxin, has not been fully investigated. Phagocytosis and lymphocyte proliferation were evaluated following in vitro and in vivo exposure to assay direct vs indirect effects. Mice were injected intraperitoneally with a single dose of DA (2.5 µg/g b.w.) and sampled after 12, 24, or 48 hr. In a separate experiment, leukocytes and splenocytes were exposed in vitro to 0, 1, 10, or 100 µM DA. In vivo exposure resulted in a significant increase in monocyte phagocytosis (12-hr), a significant decrease in neutrophil phagocytosis (24-hr), a significant decrease in monocyte phagocytosis (48-hr), and a significant reduction in T-cell mitogen-induced lymphocyte proliferation (24-hr). In vitro exposure significantly reduced neutrophil and monocyte phagocytosis at 1 µM. B- and T-cell mitogen-induced lymphocyte proliferation were both significantly increased at 1 and 10 µM, and significantly decreased at 100 µM. Differences between in vitro and in vivo results suggest that DA may exert its immunotoxic effects both directly and indirectly. Modulation of cytosolic calcium suggests that DA exerts its effects through ionotropic glutamate subtype surface receptors at least on monocytes. This study is the first to identify DA as an immunotoxic chemical in a mammalian species.
Share & Cite This Article
Levin, M.; Leibrecht, H.; Ryan, J.; Van Dolah, F.; De Guise, S. Immunomodulatory Effects of Domoic Acid Differ Between In vivo and In vitro Exposure in Mice. Mar. Drugs 2008, 6, 636-659.View more citation formats
Levin M, Leibrecht H, Ryan J, Van Dolah F, De Guise S. Immunomodulatory Effects of Domoic Acid Differ Between In vivo and In vitro Exposure in Mice. Marine Drugs. 2008; 6(4):636-659.Chicago/Turabian Style
Levin, Milton; Leibrecht, Heather; Ryan, James; Van Dolah, Frances; De Guise, Sylvain. 2008. "Immunomodulatory Effects of Domoic Acid Differ Between In vivo and In vitro Exposure in Mice." Mar. Drugs 6, no. 4: 636-659.